U.S. industry body says India agreed to not issue 'compulsory' drug licenses

MUMBAI (Reuters) - India has given private assurances that it will not grant licenses allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a U.S. business advocacy group said.